⌘K

Login Start Free

Home/Filings/4/0001333277-21-000025

4//SEC Filing

TRUEX PAUL F 4

Accession 0001333277-21-000025

CIK 0001042074other

View on SEC.gov Company Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 3:00 PM ET

Size

5.3 KB

Accession

0001333277-21-000025

Insider Transaction Report

Form 4

Period: 2021-01-26

CymaBay Therapeutics, Inc.CBAY

Director

Transactions

Award
Stock Option (right to buy)
2021-01-26+32,000→ 32,000 total
Exercise: $5.78Exp: 2031-01-25→ Common Stock (32,000 underlying)

Footnotes (1)

[F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2021.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1

filerCIK 0001120362

Filing Metadata

Form type: 4
Filed: Jan 27, 7:00 PM ET
Accepted: Jan 28, 3:00 PM ET
Size: 5.3 KB

View on SEC.gov